Filing history

Where it standsLEGN screens as non-distressed from a leverage perspective: total debt is zero and cash is $901.9M, so net leverage is not above any threshold. Negative EBITDA (-$136.5M) and net income (-$296.8M) are notable, but the distress rule requires high net leverage alongside thin or negative margins; the balance sheet does not meet that condition. Cash burn against reported cash implies runway is beyond 24 months even on the net-loss measure, and LEGN is not a pre-revenue name. No product/customer concentration data or credible competitive threat is present in the supplied facts/signals, and no order book-to-bill, MedTech customer capex, RadTech ARAY, or ISRG compounder conditions apply. No new EDGAR filing was detected. Therefore no advisory flags fired.